BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14585038)

  • 21. Expression of high p53 levels in colorectal cancer: a favourable prognostic factor.
    Adrover E; Maestro ML; Sanz-Casla MT; del Barco V; Cerdán J; Fernández C; Balibrea JL
    Br J Cancer; 1999 Sep; 81(1):122-6. PubMed ID: 10487622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
    Begum FD; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Bock JE; Glud E; Høyer-Hansen G; Ring-Larsen H; Høgdall EV
    Anticancer Res; 2004; 24(3b):1981-5. PubMed ID: 15274388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
    J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer.
    Imada T; Rino Y; Hatori S; Takahashi M; Amano T; Kondo J; Suda T
    Hepatogastroenterology; 1999; 46(25):208-14. PubMed ID: 10228794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer.
    Ytting H; Christensen IJ; Thiel S; Jensenius JC; Nielsen HJ
    Hum Immunol; 2008 Jul; 69(7):414-20. PubMed ID: 18638656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
    Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
    Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
    Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
    Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma?
    Cengiz O; Kocer B; Sürmeli S; Santicky MJ; Soran A
    Med Sci Monit; 2006 Jun; 12(6):CR240-7. PubMed ID: 16733481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
    Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
    Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.